Susan's Place Logo

News:

Since its founding in 1995 Susan's Place forums have blossomed into a truly global lifeline. To date we've delivered roughly 1.4 billion page views to hundreds of millions of unique visitors, guided more than 41,000 registered members through 1,985,081 posts and 188,474 topics across 193 boards, and—most importantly—helped save tens of thousands of lives by connecting people to vital information and support at their most vulnerable moments.

Main Menu

Androgen therapy may slow progress of Alzheimer's disease

Started by LostInTime, December 20, 2006, 11:13:31 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

LostInTime

Link

The research team established a correlation between low testosterone and elevated beta-amyloid (Aâ), a protein that accumulates abnormally in Alzheimer's disease patients. This finding, they say, suggests that testosterone depletion in aging men may be a risk factor for AD by promoting accumulation of Aâ in the brain. Testosterone, the primary male sex hormone, is one in a group of related steroid hormones referred to as androgens. Recent studies suggest that androgens may lower Aâ levels.

  •